These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 12400131)

  • 1. [Betaserc treatment of acute disorders of cerebral circulation with vestibulo-ataxic and cochleo-vestibular syndromes].
    Berdichevskiĭ MIa; Karmirian SA; Geĭko II; Miroshnichenko VE; Parkhaeva TN; Popova VG; Timchenko LV; Filina TV; Aristova LA
    Vestn Otorinolaringol; 2002; (4):32-3. PubMed ID: 12400131
    [No Abstract]   [Full Text] [Related]  

  • 2. [Future treatment of stroke. Brain damage in stroke can be reduced by drugs].
    Siesjö BK
    Lakartidningen; 1993 Sep; 90(36):2958, 2962-4. PubMed ID: 8366724
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of seduxen to arrest acute cochleovestibular syndromes in transient cerebral disorders].
    Bakhur VT; Zaikin VS; Voronin TS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(8):1134-7. PubMed ID: 696100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A use of betaserc in ataxic syndromes].
    Prokopenko SV; Rudnev VA; Afanas'eva EV; Abramov VG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(8):41-5. PubMed ID: 15554141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemodynamic disturbances and the means for their pharmacological correction in transient disorders of cerebral circulation and ischemic stroke].
    Vinichuk SM
    Vrach Delo; 1986 Feb; (2):37-41. PubMed ID: 3705565
    [No Abstract]   [Full Text] [Related]  

  • 6. Orally administered betahistine and regional cerebral blood flow in cerebrovascular disease.
    Meyer JS; Mathew NT; Hartmann A; Rivera VM
    J Clin Pharmacol; 1974; 14(5-6):280-9. PubMed ID: 4208360
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic approach to TIA and acute cerebral stroke in geriatric patients using a platelet aggregation inhibiting and vasoactive drug].
    Cucinotta D; Monica C; Silvestrini C; Ceccato S; Cocchi C
    G Clin Med; 1979 Apr; 60(4):301-9. PubMed ID: 488589
    [No Abstract]   [Full Text] [Related]  

  • 8. Reevaluating obstructive sleep apnea as a risk factor for cerebrovascular disease.
    Attarian H
    J Stroke Cerebrovasc Dis; 2010; 19(5):337-9. PubMed ID: 20816348
    [No Abstract]   [Full Text] [Related]  

  • 9. [Betaserk efficiency in cochlear and vestibular disorders in the regional surdocenter].
    Pekaskiĭ SI
    Vestn Otorinolaringol; 2001; (3):61. PubMed ID: 11510053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compendium of cerebrovascular diseases.
    Rafii MS; Hillis AE
    Int Rev Psychiatry; 2006 Oct; 18(5):395-407. PubMed ID: 17085359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of betaserk in combined treatment of neurosensory hypoacusis and vestibulopathy in childhood].
    Chistiakova VR
    Vestn Otorinolaringol; 2004; (2):9-12. PubMed ID: 15111941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of betahistine for the prevention of seasickness: effect on vestibular function, psychomotor performance and efficacy at sea.
    Gordon CR; Doweck I; Nachum Z; Gonen A; Spitzer O; Shupak A
    J Vestib Res; 2003; 13(2-3):103-11. PubMed ID: 14757913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischemic stroke syndromes: classification, pathophysiology and clinical features.
    Stone WM
    Med Health R I; 1998 Jun; 81(6):197-203. PubMed ID: 9654896
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of ischemic brain lesions].
    Eichhorn O
    Med Welt; 1969 Oct; 42():2314-8. PubMed ID: 4982284
    [No Abstract]   [Full Text] [Related]  

  • 15. Sleep disorderd breathing and recurrence of cerebrovascular events, case-fatality, and functional outcome in patients with ischemic stroke or transient ischemic attack.
    Rola R; Jarosz H; Wierzbicka A; Wichniak A; Richter P; Ryglewicz D; Jernajczyk W
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():615-21. PubMed ID: 19218688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vincamine in the treatment of minor ictus (due to transient cerebral ischemia)].
    Franzini C; Ferrante P
    Minerva Med; 1974 Apr; 65(29):1631-41. PubMed ID: 4599654
    [No Abstract]   [Full Text] [Related]  

  • 17. [The use of betaserk in patients with cochlear-vestibular disorders].
    Kadymov MI; Poliakova TS; Vladimirova TN
    Vestn Otorinolaringol; 1998; (5):49-50. PubMed ID: 9793432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histamine and betahistine in the treatment of vertigo: elucidation of mechanisms of action.
    Lacour M; Sterkers O
    CNS Drugs; 2001; 15(11):853-70. PubMed ID: 11700150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New treatments for acute stroke.
    Schehr RS
    Nat Biotechnol; 1996 Nov; 14(11):1549-54. PubMed ID: 9634819
    [No Abstract]   [Full Text] [Related]  

  • 20. [The new cerebrovascular preparation pikamilon].
    Mirzoian RS; Gan'shina TS
    Farmakol Toksikol; 1989; 52(1):23-6. PubMed ID: 2707413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.